Journal Mobile Options
Table of Contents
Vol. 204, No. 4, 2002
Issue release date: 2002

Skin Tensile Properties in Patients Treated for Acromegaly

Braham C. · Betea D. · Piérard-Franchimont C. · Beckers A. · Piérard G.E.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Background: Somatotropic effects are described in the skin. Indeed, acromegaly is in part clinically recognized by cutaneous coarsening. The actual changes in tensile properties associated with the cutaneous manifestations are largely unknown. Objectives: To study the relationships between the skin tensile properties and the severity of acromegaly as assessed by serum levels of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). Patients and Method: Assessments were made in 13 patients with acromegaly treated by somatostatin agonists combined or not with surgery. A total of 39 age- and sex-matched healthy subjects served as controls. Skin tensile properties were measured on the forearm and nape of the neck using a computerized suction device. Results: Significant differences were yielded between the skin tensile properties in patients and normal subjects. The highest IGF-1 values in the patients’ medical records were positively correlated with both skin distensibility and biologic elasticity. The most recent IGF-1 serum levels were negatively correlated with the visco-elastic ratio. No correlations were yielded between any of the biomechanical parameters and GH levels, disease duration and treatment dosages, respectively. Conclusion: The skin in acromegaly appears to be functionally more redundant and elastic than normal skin. The biomechanical changes appear quite different from those observed in other diseases with collagen deposition such as diabetes mellitus and scleroderma.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Piérard GE and the EEMCO group: EEMCO guidance to the in vivo assessment of tensile functional properties of the skin. 1. Relevance to the structures and ageing of the skin and subcutaneous tissues. Skin Pharmacol Appl Skin Physiol 1999;12:352–362.
  2. Marks R: Mechanical properties of the skin; in Goldsmith LA (ed): Biomechemistry and Physiology of the Skin. New York, Oxford University Press, 1983, pp 1237–1254.
  3. Piérard GE, Henry F: Essai de classement catégoriel des propriétés biomécaniques de la peau: évaluations par la méthode de succion. Nouv Dermatol 1995;14:630–636.
  4. Rodrigues L and the EEMCO group: EEMCO guidance to the in vivo assessment of tensile functional properties of the skin. 2. Instrumentation and test modes. Skin Pharmacol Appl Skin Physiol 2001;14:52–61.
  5. Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG: Acromegaly: Clinical and biochemical features in 500 patients. Medicine 1994;73:233–240.
  6. Thiboutot DM: Dermatological manifestations of endocrine disorders. J Clin Endocrinol Metab 1995;80:3082–3087.
  7. Gabrilove JL, Schwartz A, Churg J: Effect of hormones on the skin in endocrinologic diseases. J Clin Endocrinol Metab 1962;22:688–692.
  8. Matsuoka LY, Wortsman J, Kupchella CE, Eng A, Dietrich JE: Histochemical characterization of the cutaneous involvement of acromegaly. Arch Intern Med 1982;142:1820–1823.
  9. Jorgensen PH, Andreassen TT, Jorgensen KD: Growth hormone influences collagen deposition and mechanical strength of intact rat skin. Acta Endocrinol 1989;120:767–772.
  10. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE: Effects of growth hormone in men over 60 year old. N Engl J Med 1990;323:1–6.
  11. Piérard-Franchimont C, Henry F, Crielaard JM, Piérard GE: Mechanical properties of skin in recombinant human growth factor abusers among adult body builders. Dermatology 1996;192:389–392.
  12. Barkan AL, Beitins IZ, Kelch RP: Plasma insulin-like growth factor-1/somatomedin-C in acromegaly: Correlation with the degree of growth hormone secretion. J Clin Endocrinol Metab 1988;67:69–73.
  13. Lobie PE, Breipohl W, Lincoln DT, Garcia-Aragon J, Waters MJ: Localization of the growth hormone receptor/binding protein in skin. J Endocrinol 1990;126:467–472.
  14. Granot I, Halevy O, Hurwitz SA, et al: Growth hormone and insulin-like growth factor I regulate collagen gene expression and extracellular collagen in cultures of avian skin fibroblasts. Mol Cell Endorinol 1991;80:1–9.
  15. Jorgensen O: Human growth hormone replacement therapy: Pharmacological and clinical aspects. Endocr Rev 1991;121:189–207.
  16. Lobie PE, Garcia-Aragon J, Wang BS, Baumbach WR, Waters MJ: Cellular localization of the growth hormone binding protein in the rat. Endocrinology 1992;130:3057–3065.
  17. Oakes SR, Haynes KM, Waters MJ, Herington AC, Werther GA: Demonstration and localization of growth hormone receptor in human skin and skin fibroblast. J Clin Endocrinol Metab 1992;75:1368–1373.
  18. Tavakkol A, Elder JT, Griffiths CEM, Cooper KD, Talwar H, Fischer GJ, Keane KM, Foltin SK, Voorhees JJ: Expression of growth hormone receptor insulin-like growth factor (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J Invest Dermatol 1992;99:343–349.
  19. Batch JA, Mercuri FA, Edmondson SR, Werther GA: Localization of messenger ribonucleic acid for insulin-like growth factor-binding proteins in human skin by in situ hybridization. J Clin Endocrinol Metab 1994;79:1444–1449.
  20. Deplewski D, Rosenfield RL: Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 1999;140:4089–4094.
  21. Edmondson SR, Russo VC, McFarlane AC, Wraight CJ, Werther GA: Interactions between growth hormone, insulin-like growth factor I, and basic growth factor in melanocyte growth. J Clin Endocrinol Metab 1999;84:1638–1644.
  22. Slominski A, Wortsman J: Neuroendocrinology of the skin. Endocr Rev 2000;21:457–487.
  23. Wanke R, Milz Z, Rieger N, Ogiolda L, Renner-Muller I, Brem G, Hermanns W, Wolf E: Overgrowth of skin in growth hormone transgenic mice depends on the presence of male gonads. J Invest Dermatol 1999;113:967–971.
  24. Gilhar A, Ish-Shalom S, Pillar T, Etzioni A, Silbermann M: Effect of anti-insulin-like growth factor I on epidermal proliferation of human skin transplanted onto nude mice treated with growth hormone. Endocrinology 1994;234:229–232.
  25. Conte F, Diridollou S, Joret B, Turlier V, Charveron M, Gall Y, Rochiccioli P, Bieth E, Tauber M: Evaluation of cutaneous modifications in seventy-seven growth hormone-deficient children. Horm Res 2000;134:229–232.
  26. Henry F, Goffin V, Piérard-Franchimont C, Piérard GE: Mechanical properties of skin in Ehlers-Danlos syndrome, types I, II and III. Pediatr Dermatol 1996;13:464–467.
  27. Nikkels-Tassoudji N, Henry F, Piérard-Franchimont C, Piérard GE: Computerized evaluation of skin stiffening in scleroderma. Eur J Clin Invest 1996;26:457–460.
  28. Nikkels-Tassoudji N, Henry F, Letawe C, Piérard-Franchimont C, Lefebvre P, Piérard GE: Mechanical properties of the diabetic waxy skin. Dermatology 1996;192:19–22.
  29. Piérard-Franchimont C, Nikkels-Tassoudji N, Lefebvre P, Piérard GE: Subclinical skin stiffening in adults suffering from type 1 diabetes mellitus: A comparison with Raynaud’s syndrome. J Med Eng Technol 1998;22:206–210.
  30. Piérard GE, Piérard-Franchimont C, Vanderplaetsen S, Franchimont N, Gaspard U, Malaise M: Relationships between bone mass density and tensile properties of skin in women. Eur J Clin Invest 2001;31:731–735.
  31. Piérard GE, Letawe C, Dowlati A, Piérard-Franchimont C: Effect of hormone replacement therapy for menopause on the mechanical properties of skin. J Am Geriatr Soc 1995;43:662–665.
  32. Callens A, Vaillant L, Lecomte P, Berson M, Gall Y, Lorette G: Does hormonal skin aging exist? A study of the influence of different hormone therapy regimens on the skin of post-menopausal women using non-invasive measurement techniques. Dermatology 1996;193:289–294.
  33. Piérard-Franchimont C, Cornil C, Dehavay J, Letot B, Deleixhe-Mauhin F, Piérard GE: Climacteric skin ageing of the face: A prospective longitudinal intent-to-treat trial on the effect of oral hormone replacement therapy. Maturitas 199;32:87–93.
  34. Diridollou S, Black D, Lagarde JM, Gall Y, Berson M, Vabre V, Patat F, Vaillant L: Sex and site-dependent variations in the thickness and the mechanical properties of human skin in vivo. Int J Cosmet Sci 2000;22:421–435.
  35. Finkelstein JW, Boyar RM, Roffwarg HP, Kream J, Hellman L: Age-related change in the twenty-four-hour spontaneous secretion of growth hormone. J Clin Endocrinol Metab 1972;35:665–670.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50